Soo, we have a lot of stuff now in the pipeline...seems like Oct-Jan timeframe is getting pretty full...pls lemme know if I missed something
- US FDA (Access Bio-AT1 AB test approval) (Oct?) + subsequent 77k device supply (Oct-Dec?) or more
- India (Divoc-AT1 AB test submission-approval (Oct-Dec)
- AU PDI (Access Bio-AT1 AB test review) (Nov-Dec?)
- PH, TW, HK (Access Bio-AT1 AB test submission-approval) (Oct-Jan?)
- AU, NZ, India (Access Bio-At1 AG test submission-approval) (Oct-Dec?)
- India (NG Biotech-AT1 AB test approval (Dec?)
+
- AT1 1.3m/mth scale-up done (by Jan)
+
- AT1 brand tests (AB first and then later AG) getting orders for AU market (Oct-Jan)?
- NG Biotech hopefully taking up remainder of their original order + asking more for EU (by Jan or anytime)?
- NG Biotech finishing antigen clinical trials (nasal, blood, Q4 2020) + hopefully partnering with AT1 device for blood (Jan?)
- Lumos Diagnostics finishing USA FebriDx clinical trials (Q4 2020) + hopefully ordering more for UK&I/EU markets (Q1 2021?)
+
Nov2020 AGM to prep for
....reckon more busy times now than even pre-IPO @AT1 HQ...
- Forums
- ASX - By Stock
- Ann: Atomo & Access Bio sign deal for rapid antigen test
Soo, we have a lot of stuff now in the pipeline...seems like...
-
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.25M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.5¢ | $2.064K | 76.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 515868 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 51595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 515868 | 0.025 |
2 | 617050 | 0.024 |
3 | 893000 | 0.023 |
6 | 564373 | 0.022 |
4 | 432292 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 51595 | 1 |
0.028 | 208639 | 3 |
0.029 | 452248 | 7 |
0.030 | 632393 | 9 |
0.031 | 159930 | 3 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online